Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12504039rdf:typepubmed:Citationlld:pubmed
pubmed-article:12504039lifeskim:mentionsumls-concept:C0008976lld:lifeskim
pubmed-article:12504039lifeskim:mentionsumls-concept:C1522449lld:lifeskim
pubmed-article:12504039lifeskim:mentionsumls-concept:C0034656lld:lifeskim
pubmed-article:12504039lifeskim:mentionsumls-concept:C2349952lld:lifeskim
pubmed-article:12504039lifeskim:mentionsumls-concept:C0439858lld:lifeskim
pubmed-article:12504039lifeskim:mentionsumls-concept:C0205179lld:lifeskim
pubmed-article:12504039lifeskim:mentionsumls-concept:C0521115lld:lifeskim
pubmed-article:12504039pubmed:issue1lld:pubmed
pubmed-article:12504039pubmed:dateCreated2002-12-30lld:pubmed
pubmed-article:12504039pubmed:abstractTextTo compare conventional fractionation radiation therapy (RT), Arm A, vs. split-course accelerated hyperfractionated RT (S-AHF), Arm B, vs. conventional fractionation RT plus concomitant chemotherapy (CT), Arm C, in terms of survival and toxicity for advanced, unresectable epidermoid tumors of oropharynx.lld:pubmed
pubmed-article:12504039pubmed:languageenglld:pubmed
pubmed-article:12504039pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12504039pubmed:citationSubsetIMlld:pubmed
pubmed-article:12504039pubmed:statusMEDLINElld:pubmed
pubmed-article:12504039pubmed:monthJanlld:pubmed
pubmed-article:12504039pubmed:issn0360-3016lld:pubmed
pubmed-article:12504039pubmed:authorpubmed-author:ColomboAlessa...lld:pubmed
pubmed-article:12504039pubmed:authorpubmed-author:AmichettiMaur...lld:pubmed
pubmed-article:12504039pubmed:authorpubmed-author:RossiFrancesc...lld:pubmed
pubmed-article:12504039pubmed:authorpubmed-author:FranchinGiova...lld:pubmed
pubmed-article:12504039pubmed:authorpubmed-author:OlmiPatriziaPlld:pubmed
pubmed-article:12504039pubmed:authorpubmed-author:BolnerAndreaAlld:pubmed
pubmed-article:12504039pubmed:authorpubmed-author:TorriValterVlld:pubmed
pubmed-article:12504039pubmed:authorpubmed-author:MinatelEmilio...lld:pubmed
pubmed-article:12504039pubmed:authorpubmed-author:GobittiCarloClld:pubmed
pubmed-article:12504039pubmed:authorpubmed-author:CrispinoSergi...lld:pubmed
pubmed-article:12504039pubmed:authorpubmed-author:FallaiCarloClld:pubmed
pubmed-article:12504039pubmed:authorpubmed-author:SignorMarcoMlld:pubmed
pubmed-article:12504039pubmed:authorpubmed-author:TainoRaffaell...lld:pubmed
pubmed-article:12504039pubmed:authorpubmed-author:SquadrelliMas...lld:pubmed
pubmed-article:12504039pubmed:authorpubmed-author:ArdizzoiaAles...lld:pubmed
pubmed-article:12504039pubmed:authorpubmed-author:PonticelliPie...lld:pubmed
pubmed-article:12504039pubmed:authorpubmed-author:AtzeniGuidoGlld:pubmed
pubmed-article:12504039pubmed:authorpubmed-author:GavaAlessandr...lld:pubmed
pubmed-article:12504039pubmed:authorpubmed-author:FlannMonicaMlld:pubmed
pubmed-article:12504039pubmed:authorpubmed-author:MarsoniSilvia...lld:pubmed
pubmed-article:12504039pubmed:issnTypePrintlld:pubmed
pubmed-article:12504039pubmed:day1lld:pubmed
pubmed-article:12504039pubmed:volume55lld:pubmed
pubmed-article:12504039pubmed:ownerNLMlld:pubmed
pubmed-article:12504039pubmed:authorsCompleteYlld:pubmed
pubmed-article:12504039pubmed:pagination78-92lld:pubmed
pubmed-article:12504039pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:12504039pubmed:meshHeadingpubmed-meshheading:12504039...lld:pubmed
pubmed-article:12504039pubmed:meshHeadingpubmed-meshheading:12504039...lld:pubmed
pubmed-article:12504039pubmed:meshHeadingpubmed-meshheading:12504039...lld:pubmed
pubmed-article:12504039pubmed:meshHeadingpubmed-meshheading:12504039...lld:pubmed
pubmed-article:12504039pubmed:meshHeadingpubmed-meshheading:12504039...lld:pubmed
pubmed-article:12504039pubmed:meshHeadingpubmed-meshheading:12504039...lld:pubmed
pubmed-article:12504039pubmed:meshHeadingpubmed-meshheading:12504039...lld:pubmed
pubmed-article:12504039pubmed:meshHeadingpubmed-meshheading:12504039...lld:pubmed
pubmed-article:12504039pubmed:meshHeadingpubmed-meshheading:12504039...lld:pubmed
pubmed-article:12504039pubmed:meshHeadingpubmed-meshheading:12504039...lld:pubmed
pubmed-article:12504039pubmed:meshHeadingpubmed-meshheading:12504039...lld:pubmed
pubmed-article:12504039pubmed:meshHeadingpubmed-meshheading:12504039...lld:pubmed
pubmed-article:12504039pubmed:meshHeadingpubmed-meshheading:12504039...lld:pubmed
pubmed-article:12504039pubmed:meshHeadingpubmed-meshheading:12504039...lld:pubmed
pubmed-article:12504039pubmed:meshHeadingpubmed-meshheading:12504039...lld:pubmed
pubmed-article:12504039pubmed:meshHeadingpubmed-meshheading:12504039...lld:pubmed
pubmed-article:12504039pubmed:year2003lld:pubmed
pubmed-article:12504039pubmed:articleTitleLocoregionally advanced carcinoma of the oropharynx: conventional radiotherapy vs. accelerated hyperfractionated radiotherapy vs. concomitant radiotherapy and chemotherapy--a multicenter randomized trial.lld:pubmed
pubmed-article:12504039pubmed:affiliationRep. di Radioterapia, Dipartimento di Fisiopatologia Clinica, Università, Firenze, Italy.lld:pubmed
pubmed-article:12504039pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:12504039pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:12504039pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:12504039pubmed:publicationTypeRandomized Controlled Triallld:pubmed
pubmed-article:12504039pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:12504039pubmed:publicationTypeMulticenter Studylld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12504039lld:pubmed